Consulting services for drug metabolism and pharmacokinetics
Official title: DRUG METABOLISM AND PHARMACOKINETICS (DMPK) CONSULTING SUPPORT SERVICES
Funded at Allucent Government Services (Us) LLC · NIH-11211322 · Data updated 2026-11-12
This study is helping to improve how new drugs are developed by finding and solving problems in the process, which could lead to better treatment options for patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Allucent Government Services (Us) LLC NIH-funded |
| Lab location | 1 site (Cary, United States) |
| Project start | July 1, 2022 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $46,020 |
| NIH project number | 75N95022P00352-P00006-0-2 |
| Project ID | NIH-11211322 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals with conditions that require new or optimized drug therapies.
✕Less likely to help
Patients who are not seeking new treatments or those with conditions that are not addressed by the drugs being developed may not benefit from this research.
What this research studies
This research provides consulting support to the NIH Blueprint Neurotherapeutics Network by evaluating pharmacokinetics study protocols and data. It aims to identify challenges in drug discovery and development and recommend strategies to overcome these obstacles. The project also involves assisting in the design of pharmacokinetics studies and managing programs that facilitate drug development activities. Patients may benefit indirectly through improved drug development processes and better therapeutic options.
Why it matters
Potential benefit: If successful, this research could lead to more effective drug therapies and improved treatment options for patients.
How similar studies have gone: Similar research efforts have shown success in improving drug development processes, indicating that this approach is promising.
Where this research is happening
-
Allucent Government Services (Us) LLC
Cary, United States Active
Related research
Other NIH-funded projects on the same topics.
-
Sub-second acetylcholine release in the brain for Alzheimer’s dementia
A small, quick stimulations-based study aims to boost a brain chemical called acetylcholine to help people with Alzheimer’s disease by using a targeted brain stimulation approach.
-
Understanding how broadly neutralizing antibodies may help HIV cure trials
A study at UC San Francisco looks at how antibody medicines behave in people on and off HIV therapy to help design better cure strategies.
-
Improving HIV-related brain infections by studying how drugs reach the brain
This grant looks at how well drugs reach the brain and spine to treat HIV-related infections like cryptococcal meningitis and TB meningitis in people with AIDS.
-
Transdermal delivery patch for zanamivir to treat influenza in patients
A new skin patch delivers zanamivir to people with flu or at risk of flu, aiming for easier, safer treatment than pills.
-
Chesapeake-Ohio Pharmacokinetics Core supports cancer drug testing
A collaborative core lab helps researchers study how cancer drugs behave in the body to improve clinical trials and patient care.
-
Urine color test to check tuberculosis drug levels in children and adults
This project uses a simple urine color test to see whether children and adults with TB are getting enough of key TB medicines like rifampin.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.